Status:
COMPLETED
SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization
Lead Sponsor:
UCB Pharma
Conditions:
Epilepsy
Eligibility:
All Genders
16-70 years
Phase:
PHASE3
Brief Summary
Male and female patients between 16 and 70 years of age who are diagnosed with epilepsy with partial seizures and are taking up to 3 medications for this medical condition will take part in a research...
Eligibility Criteria
Inclusion
- Epilepsy with partial seizures
Exclusion
- Subject received SPM 927 in a previous trial
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2006
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00136019
Start Date
March 1 2004
End Date
August 1 2006
Last Update
September 22 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.